Welcome to the Research Institute of Internal Medicine
The research profile of the Institute is to combine clinical medicine and molecular biology to establish a bridge between bench and bedside. This is of utmost importance in order to exploit in clinical medicine the recent development in immunology, biochemistry and molecular biology with the ambitious aim to develop novel treatment modalities and new diagnostic tools. Our profile includes all phases of this research, ranging from characterization of inflammatory profiles in various patient populations and in vitro experiments in various cells and cell lines to experimental studies in animal models, including gene modified mice, and interventional proof of concept studies in various patient populations.
Read more about our research here
Research groups at RIIM
| Professor Pål Aukrust is leading the groups that focus on inflammatory and immunological research (group 1-4) | ![]() |
| 1. Inflammatory and molecular mechanisms in atherosclerosis and related metabolic disorders Group leader: Bente Halvorsen |
![]() |
2. Immunological and molecular mechanisms in myocardial remodeling and heart failure Group leader: Arne Yndestad |
|
3. Endocrinology, inflammation and cardiovascular disorders including the study of biomarkers Group leader: Thor Ueland |
![]() |
4. Immunopathogenic mechanisms in immunodeficiency and infectious disorders Group leader: Børre Fevang |
|
5. Platelet and coagulation: clinical and basic research Group leader: Pål André Holme |
|
6. Functional genetics in primary sclerosing cholangitis Group leader: Tom Hemming Karlsen |
|
May 7, 2012
Latest publications
Research Inst. for Internal Medicine
Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly
J Clin Endocrinol Metab (in press)
PubMed 22585092
Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort
Eur J Gastroenterol Hepatol (in press)
PubMed 22584257
Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
Gut (in press)
PubMed 22580416











Print this page
